Peripheral Edema Some patients taking insulin glargine products have experienced sodium retention and edema, particularly if previously poor metabolic control was improved by intensified insulin therapy
With UK Government statistics revealing that 64% of adults are estimated to be overweight or living with obesity, the use of GLP-1s is expected to rise further, reshaping shopping habits and opening up opportunities for healthier, nutrient-rich foods
As well as supporting weight management, they reduce the risk of cardiovascular disease and can prevent the onset of type 2 diabetes
Reported side effects are generally mild and may include: Injection site reactions (redness, swelling) Temporary water retention Headaches (typically mild and transient) Nausea (rare and usually dose-related) Comparison to other peptides Unlike growth hormone secretagogues like MK-677 or CJC-1295, AOD 9604 doesnt stimulate natural HGH production
Personalized Dosing : Compounding allows for flexibility in dosing to meet individual patient needs as directed by their provider